Type 2 diabetes (ICD-10: E11) and follow-up in general practice. Nutritional, Metabolic, Endocrine
Conditions
Interventions
The intervention consists of replacing annual in-person follow-up with a digital annual follow-up every second year.
In this setting, digital annual follow-up means that communication between healt
Sponsors
Steno Diabetes Centers
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. eGFR >59 mL/min/1.73 m² 2. HbA1c: 2.1. <48 mmol/mol, or 2.2. 48–53 mmol/mol if the individual HbA1c treatment target is <53 mmol/mol 3. Urine albumin-to-creatinine ratio (UACR): 3.1. <30 mg/g, or 3.2. 30–300 mg/g with ongoing treatment with organ-protective medication: SGLT-2i or GLP1 agonist and RAS-blockade with ACE-I or ARB (ATC-code: C09, A10BK, A10BD, A10BJ) 4. LDL <2.6 mmol/L 5. Ability to use the Danish national healthcare website (www.sundhed.dk) 6. Ability to read and understand Danish
Exclusion criteria
Exclusion criteria: 1. The following diagnosis, ICD-10 codes: 1.1. F00–F03: Dementia – all forms 1.2. F70-F79: Intellectual disability 1.3. I50: Heart failure 1.4. Z51.5: Palliative care. 1.5. Pregnancy (ICD-10 O00-O99) 2. Any diagnoses or circumstances, that by the GPs judgement, makes digital annual follow-up inadvisable or unsafe
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glycated haemoglobin (HbA1c) measured using analysis of blood samples by the local Department of Clinical Biochemistry following standardized accredited procedures, with data obtained from medical records and the BI Data Warehouse for Central Region Denmark at baseline, 1 and 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Total cholesterol level measured using analysis of blood samples by the local Department of Clinical Biochemistry following standardized accredited procedures, with data obtained from medical records and the BI Data Warehouse for Central Region Denmark at baseline, 1 year, and 2 years;Low-density lipoprotein (LDL) cholesterol level measured using analysis of blood samples by the local Department of Clinical Biochemistry following standardized accredited procedures, with data obtained from medical records and the BI Data Warehouse for Central Region Denmark at baseline, 1 year, and 2 years;Urinary albumin-to-creatinine ratio (UACR) measured using analysis of urine samples by the local Department of Clinical Biochemistry following standardized accredited procedures, with data obtained from medical records and the BI Data Warehouse for Central Region Denmark at baseline, 1 year, and 2 years;Estimated glomerular filtration rate (eGFR) measured using analysis of blood samples by the local Department of Clinical Biochemistry following standardized accredited procedures, with data obtained from medical records and the BI Data Warehouse for Central Region Denmark at baseline, 1 year, and 2 years;Smoking status measured using participant medical records and GP records at baseline, 1 year, and 2 years;Weight measured using self-reported weight recorded on a personal bathroom scale or weight recorded in GP practice records at baseline, 1 year, and 2 years;Blood pressure measured using home arm-cuff monitoring (three measurements each morning and three each evening for three consecutive days, averaged across all measurements and recorded in Webpatient.dk) or GP practice records at baseline, 1 year, and 2 years;Primary healthcare utilization measured using the total number of GP consultations (face-to-face, telephone, video, or email) obtained from medical records and the BI Data Warehouse for Central Region Denmark at baseline, 1 year, and 2 years;Secondary healthcare utilizati | — |
Countries
Denmark
Contacts
Public ContactKirsten Christensen
Outcome results
None listed